Literature DB >> 19496731

Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative.

Howard E Jeffries1, Wilbert Mason, Melanie Brewer, Katie L Oakes, Esther I Muñoz, Wendi Gornick, Lee D Flowers, Jodi E Mullen, Craig Harris Gilliam, Stana Fustar, Cary W Thurm, Tina Logsdon, William R Jarvis.   

Abstract

OBJECTIVE: The goal of this effort was to reduce central venous catheter (CVC)-associated bloodstream infections (BSIs) in pediatric intensive care unit (ICU) patients by means of a multicenter evidence-based intervention.
METHODS: An observational study was conducted in 26 freestanding children's hospitals with pediatric or cardiac ICUs that joined a Child Health Corporation of America collaborative. CVC-associated BSI protocols were implemented using a collaborative process that included catheter insertion and maintenance bundles, daily review of CVC necessity, and daily goals. The primary goal was either a 50% reduction in the CVC-associated BSI rate or a rate of 1.5 CVC-associated BSIs per 1,000 CVC-days in each ICU at the end of a 9-month improvement period. A 12-month sustain period followed the initial improvement period, with the primary goal of maintaining the improvements achieved.
RESULTS: The collaborative median CVC-associated BSI rate decreased from 6.3 CVC-associated BSIs per 1,000 CVC-days at the start of the collaborative to 4.3 CVC-associated BSIs per 1,000 CVC-days at the end of the collaborative. Sixty-five percent of all participants documented a decrease in their CVC-associated BSI rate. Sixty-nine CVC-associated BSIs were prevented across all teams, with an estimated cost avoidance of $2.9 million. Hospitals were able to sustain their improvements during a 12-month sustain period and prevent another 198 infections.
CONCLUSIONS: We conclude that our collaborative quality improvement project demonstrated that significant reduction in CVC-associated BSI rates and related costs can be realized by means of evidence-based prevention interventions, enhanced communication among caregivers, standardization of CVC insertion and maintenance processes, enhanced measurement, and empowerment of team members to enforce adherence to best practices.

Entities:  

Mesh:

Year:  2009        PMID: 19496731     DOI: 10.1086/598341

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  13 in total

1.  Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC).

Authors:  V D Rosenthal; B Ramachandran; W Villamil-Gómez; A Armas-Ruiz; J A Navoa-Ng; L Matta-Cortés; M Pawar; A Nevzat-Yalcin; M Rodríguez-Ferrer; R D Yıldızdaş; A Menco; R Campuzano; V D Villanueva; L F Rendon-Campo; A Gupta; O Turhan; N Barahona-Guzmán; O O Horoz; P Arrieta; J M Brito; M C V Tolentino; Y Astudillo; N Saini; N Gunay; G Sarmiento-Villa; E Gumus; A Lagares-Guzmán; O Dursun
Journal:  Infection       Date:  2012-02-28       Impact factor: 3.553

2.  Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.

Authors:  Matthew Kelly; Margaret Conway; Kathleen Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

3.  Infection prevention practices in neonatal intensive care units reporting to the national healthcare safety network.

Authors:  Susan N Hocevar; Fernanda C Lessa; Lauren Gallagher; Craig Conover; Rachel Gorwitz; Martha Iwamoto
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-25       Impact factor: 3.254

4.  The Epidemiology of Healthcare-associated Infections in Pediatric Cardiac Intensive Care Units.

Authors:  Jeffrey A Alten; A K M Fazlur Rahman; Hayden J Zaccagni; Andrew Shin; David S Cooper; Joshua J Blinder; Lauren Retzloff; Inmaculada B Aban; Eric M Graham; Jeffrey Zampi; Yuliya Domnina; Michael G Gaies
Journal:  Pediatr Infect Dis J       Date:  2018-08       Impact factor: 2.129

Review 5.  Are central line bundles and ventilator bundles effective in critically ill neonates and children?

Authors:  Charlotte A Smulders; Josephus P J van Gestel; Albert P Bos
Journal:  Intensive Care Med       Date:  2013-04-25       Impact factor: 17.440

6.  Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010.

Authors:  Ryan P Fagan; Jonathan R Edwards; Benjamin J Park; Scott K Fridkin; Shelley S Magill
Journal:  Infect Control Hosp Epidemiol       Date:  2013-07-16       Impact factor: 3.254

7.  Consistency between guidelines and reported practice for reducing the risk of catheter-related infection in British paediatric intensive care units.

Authors:  Katie Harron; Geethanjali Ramachandra; Quen Mok; Ruth Gilbert
Journal:  Intensive Care Med       Date:  2011-08-30       Impact factor: 17.440

8.  The German quality indicators in intensive care medicine 2013--second edition.

Authors:  Jan-Peter Braun; Oliver Kumpf; Maria Deja; Alexander Brinkmann; Gernot Marx; Frank Bloos; Arnold Kaltwasser; Rolf Dubb; Elke Muhl; Clemens Greim; Hanswerner Bause; Norbert Weiler; Ines Chop; Christian Waydhas; Claudia Spies
Journal:  Ger Med Sci       Date:  2013-07-16

9.  Implementation of a children's hospital-wide central venous catheter insertion and maintenance bundle.

Authors:  Onno Helder; René Kornelisse; Cynthia van der Starre; Dick Tibboel; Caspar Looman; René Wijnen; Marten Poley; Erwin Ista
Journal:  BMC Health Serv Res       Date:  2013-10-14       Impact factor: 2.655

10.  Pulsative flushing as a strategy to prevent bacterial colonization of vascular access devices.

Authors:  Agnès Ferroni; Florian Gaudin; Gérard Guiffant; Patrice Flaud; Jean-Jacques Durussel; Philippe Descamps; Patrick Berche; Xavier Nassif; Jacques Merckx
Journal:  Med Devices (Auckl)       Date:  2014-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.